Amgen is a big company that makes medicine. They had a good three months and made more money than people thought they would. People who buy and sell parts of Amgen were happy, so the price of those parts went up a lot. Other companies also did well and their prices went up too. Read from source...

- The title is misleading and sensationalized, implying that Amgen is the only or main reason for other stocks moving higher on Friday. In reality, there are many factors influencing the market, and it would be more accurate to say that Amgen's results contributed to the positive trend among some of the big stocks.
- The article lacks depth and substance in explaining why Amgen's results were upbeat or how they affected other companies or sectors. It merely reports the numbers without providing any context, analysis, or comparison with previous periods or expectations. For example, it does not mention what drove the revenue growth or how the Horizon acquisition impacted the company's performance.
- The article uses vague and ambiguous terms like "better-than-expected" and "higher operating and interest expenses" without defining them or clarifying their implications. This creates confusion and uncertainty for readers who are not familiar with the financial jargon or the industry dynamics. A more transparent and clear language would help convey the message more effectively and credibly.
- The article mixes different types of information, such as news, analysis, insider trading, earnings reports, and stock recommendations, without clear segmentation or separation. This makes it hard for readers to follow the logic and flow of the text, and creates a sense of clutter and chaos. A more organized and coherent structure would improve the readability and usability of the article.